SummerHaven Investment Management LLC grew its holdings in shares of Caleres, Inc. (NYSE:CAL – Free Report) by 3.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,569 shares of the textile maker’s stock after purchasing an additional 785 shares during the period. SummerHaven Investment Management LLC owned about 0.07% of Caleres worth $423,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently bought and sold shares of CAL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Caleres by 3.4% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,448 shares of the textile maker’s stock valued at $450,000 after purchasing an additional 643 shares in the last quarter. Versant Capital Management Inc boosted its position in Caleres by 244.0% in the 1st quarter. Versant Capital Management Inc now owns 1,455 shares of the textile maker’s stock valued at $25,000 after buying an additional 1,032 shares during the period. MetLife Investment Management LLC grew its stake in shares of Caleres by 6.0% in the fourth quarter. MetLife Investment Management LLC now owns 20,870 shares of the textile maker’s stock worth $483,000 after acquiring an additional 1,177 shares in the last quarter. Smartleaf Asset Management LLC grew its stake in shares of Caleres by 254.4% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,733 shares of the textile maker’s stock worth $40,000 after acquiring an additional 1,244 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in shares of Caleres by 8.5% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 30,455 shares of the textile maker’s stock worth $706,000 after acquiring an additional 2,383 shares during the period. 98.44% of the stock is currently owned by hedge funds and other institutional investors.
Caleres Stock Performance
CAL stock opened at $13.17 on Friday. The company’s 50 day moving average price is $15.40 and its 200 day moving average price is $18.62. The firm has a market capitalization of $442.67 million, a price-to-earnings ratio of 2.93 and a beta of 1.08. Caleres, Inc. has a fifty-two week low of $12.85 and a fifty-two week high of $44.51.
Caleres Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Thursday, June 5th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Thursday, June 5th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 2.13%. Caleres’s payout ratio is currently 11.67%.
Insider Transactions at Caleres
In related news, Director Lori Greeley bought 9,000 shares of the stock in a transaction dated Thursday, March 27th. The stock was acquired at an average price of $17.77 per share, for a total transaction of $159,930.00. Following the acquisition, the director now owns 10,000 shares in the company, valued at approximately $177,700. This represents a 900.00% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 4.10% of the company’s stock.
Analysts Set New Price Targets
Separately, Loop Capital decreased their target price on Caleres from $16.00 to $14.00 and set a “hold” rating for the company in a report on Friday, May 30th.
Read Our Latest Analysis on CAL
Caleres Company Profile
Caleres, Inc engages in the retail and wholesale of footwear business in the United States, Canada, East Asia, and internationally. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products. The company provides brand name athletic, casual, and dress shoes, including Nike, Skechers, adidas, Vans, Crocs, Converse, Puma, Birkenstock, New Balance, Under Armour, Dr.
Featured Articles
- Five stocks we like better than Caleres
- Stock Analyst Ratings and Canadian Analyst Ratings
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- Earnings Per Share Calculator: How to Calculate EPS
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Find and Profitably Trade Stocks at 52-Week Lows
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Caleres Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caleres and related companies with MarketBeat.com's FREE daily email newsletter.